K S Sink
Overview
Explore the profile of K S Sink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sink K, Chung A, Ressler K, Davis M, Walker D
Behav Brain Res
. 2013 Feb;
243:286-93.
PMID: 23376701
Calcitonin gene-related peptide (CGRP) acting within the bed nucleus of the stria terminalis (BNST) increases anxiety as well as neural activation in anxiety-related structures, and mediates behavioral stress responses. Similar...
2.
Sink K, Walker D, Freeman S, Flandreau E, Ressler K, Davis M
Mol Psychiatry
. 2012 Feb;
18(3):308-19.
PMID: 22290119
The lateral division of the bed nucleus of the stria terminalis (BNST), which forms part of the circuitry regulating fear and anxiety, contains a large number of neurons expressing corticotropin...
3.
Sink K, Segovia K, Collins L, Markus E, Vemuri V, Makriyannis A, et al.
Pharmacol Biochem Behav
. 2010 Mar;
95(4):479-84.
PMID: 20347865
The effects of CB1 antagonist/inverse agonists on the acquisition and consolidation of conditioned fear remain uncertain. Recent studies suggest that the CB1 antagonist/inverse agonist AM251 affects acquisition or consolidation of...
4.
Sink K, Segovia K, Sink J, Randall P, Collins L, Correa M, et al.
Eur Neuropsychopharmacol
. 2009 Dec;
20(2):112-22.
PMID: 20015619
Cannabinoid CB1 inverse agonists suppress food-motivated behaviors, but may also induce psychiatric effects such as depression and anxiety. To evaluate behaviors potentially related to anxiety, the present experiments assessed the...
5.
Sink K, Segovia K, Nunes E, Collins L, Vemuri V, Thakur G, et al.
Psychopharmacology (Berl)
. 2009 Jul;
206(2):223-32.
PMID: 19588124
Rationale: Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors and may be useful as appetite suppressants, but there is uncertainty about the locus of action for the feeding-suppression...
6.
Betz A, Vontell R, Valenta J, Worden L, Sink K, Font L, et al.
Neuroscience
. 2009 May;
163(1):97-108.
PMID: 19467297
Typical antipsychotic drugs, including haloperidol and pimozide, have been shown to produce parkinsonian motor effects such as akinesia and tremor. Furthermore, there is an antagonistic interaction between adenosine A(2A) and...
7.
Sink K, Vemuri V, Wood J, Makriyannis A, Salamone J
Pharmacol Biochem Behav
. 2008 Aug;
91(3):303-6.
PMID: 18703081
Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors, and may be clinically useful as appetite suppressants. Several CB1 receptor inverse agonists, such as rimonabant and AM251, as well...
8.
Sink K, Vemuri V, Olszewska T, Makriyannis A, Salamone J
Psychopharmacology (Berl)
. 2007 Nov;
196(4):565-74.
PMID: 18004546
Rationale: Cannabinoid CB1 antagonists/inverse agonists suppress food-motivated behaviors and are being evaluated as potential appetite suppressants. It has been suggested that the effects of CB1 antagonism on food motivation could...